Marty Whitman
Third Avenue Management
Third Avenue Management Collegium Pharmaceutical Inc stake
total: 405
Third Avenue Management COLL trades
- Total transactions:
- 7
- New positions:
- 1
- Added:
- 5
- Reduced:
- 1
- Held since:
- 2023 Q4
- Held for:
- 11 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Third Avenue Management holds 182,645 Collegium Pharmaceutical Inc (COLL) shares with a market value of roughly $6.61M accounting for 1.06% of the overall portfolio. To date, the estimated cost basis is nearly $32.57 for "buy" trades and estimated average "sell" price is $33.07. Third Avenue Management first purchased COLL in 2023 Q4, initially acquiring 83,120 shares. Since the initial investment in Collegium Pharmaceutical Inc (COLL), Third Avenue Management has made 6 more transactions.
When did Third Avenue Management buy Collegium Pharmaceutical Inc (COLL)?
Third Avenue Management first invested in Collegium Pharmaceutical Inc (COLL) in 2023 Q4 at the reported quarter-end price of $30.78 per share.
What's the cost basis of Third Avenue Management's COLL stake?
The estimated cost basis for Collegium Pharmaceutical Inc (COLL) stake is around $32.57 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $32.57
- Weighted AVG sell price:
- $33.07
Third Avenue Management's historical trades in Collegium Pharmaceutical Inc
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
1.06%
|
182,645
|
$36.20
|
$6,611,749
|
+17.73% (+27,502)
|
+0.16%
|
|
2026 Q1
|
0.83%
|
155,143
|
$33.07
|
$5,130,579
|
-23.73% (-48,258)
|
-0.29%
|
|
2024 Q4
|
1.13%
|
203,401
|
$28.65
|
$5,827,439
|
+11.36% (+20,750)
|
+0.12%
|
|
2024 Q3
|
1.15%
|
182,651
|
$38.64
|
$7,057,635
|
+0.20% (+370)
|
+0%
|
|
2024 Q2
|
1.01%
|
182,281
|
$32.20
|
$5,869,448
|
+68.59% (+74,161)
|
+0.41%
|
|
2024 Q1
|
0.67%
|
108,120
|
$38.82
|
$4,197,218
|
+30.08% (+25,000)
|
+0.15%
|
|
2023 Q4
|
0.42%
|
83,120
|
$30.78
|
$2,558,434
|
new
|
+0.42%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.